Autodisplay: Efficacious Surface Exposure of Antigenic UreA Fragments from Helicobacter pylori in Salmonella Vaccine Strains

Infection and Immunity

Volumn 71, Issue 11, 2003, Pages 6320-6328

  Rizos, Konstantin ^a,b   Lattemann, Claus T ^a,c   Bumann, Dirk ^b   Meyer, Thomas F ^b   Aebischer, Toni ^b  

^a CREATOGEN AG   (Germany)

^b MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CD4 ANTIGEN; EPITOPE; HYBRID PROTEIN; LIVE VACCINE; PROTEIN AIDA I; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG; UREASE; UREASE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; DISEASE MODEL; FEMALE; GENE EXPRESSION SYSTEM; HELICOBACTER PYLORI; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SALMONELLA; T LYMPHOCYTE;

ADHESINS, ESCHERICHIA COLI; ANIMALS; BACTERIAL VACCINES; FEMALE; HELICOBACTER PYLORI; IMMUNIZATION; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; SALMONELLA; UREASE; VACCINES, SYNTHETIC;

EID: 0242349643     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.11.6320-6328.2003     Document Type: Article

References (48)

1. Andersson, H., and G. von Heijne. 1994. Membrane protein topology: effects of delta mu H- on the translocation of charged residues explain the 'positive inside' rule. EMBO J. 13:2267-2272.
2. Angelakopoulos, H., and E. L. Hohmann. 2000. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect. Immun. 68:2135-2141.
3. Benz, I., and M. A. Schmidt. 1989. Cloning and expression of an adhesin (AIDA-I) involved in diffuse adherence of enteropathogenic Escherichia coli. Infect. Immun. 57:1506-1511.
4. + T-cell responses. Infect. Immun. 69:7493-7500.
5. Bumann, D., W. G. Metzger, E. Mansouri, O. Palme, M. Wendland, R. Hurwitz, G. Haas, T. Aebischer, B. U. von Specht, and T. F. Meyer. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 20:645-652.
6. Charbit, A., A. Molla, W. Saurin, and M. Hofnung. 1988. Versatility of a vector for expressing foreign polypeptides at the surface of gram-negative bacteria. Gene 70:181-189.
7. Chen, H., and D. M. Schifferli. 2000. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains. Infect. Immun. 69:3129-3139.
8. Corthesy-Theulaz, I. E., S. Hopkins, D. Bachmann, P. F. Saldinger, N. Porta, R. Haas, Y. Zheng-Xin, T. F. Meyer, H. Bouzourene, A. L. Blum, and J. P. Kraehenbuhl. 1998. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect. Immun. 66:581-586.
9. De Almeida, M. E., S. M. Newton, and L. C. Ferreira. 1999. Antibody responses against flagellin in mice orally immunized with attenuated Salmonella vaccine strains. Arch. Microbiol. 172:102-108.
10. DiPetrillo, M. D., T. Tibbetts, H. Kleanthous, K. P. Killeen, and E. L. Hohmann. 1999. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine 18:449-459.
11. Ermak, T. H., P. J. Giannasca, R. Nichols, G. A. Myers, J. Nedrud, R. Weltzin, C. K. Lee, H. Kleanthous, and T. P. Monath. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp Med. 188:2277-2288.
12. Ferrero, R. L., J. M. Thiberge, M. Huerre, and A. Labigne. 1994. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect. Immun. 62:4981-4989.
13. Galen, J. E., and M. M. Levine. 2001. Can a 'flawless' live vector vaccine strain be engineered? Trends Microbiol. 9:372-376.
14. Garmory, H. S., K. A. Brown, and R. W. Titball. 2002. Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol. Rev. 26:339-353.
15. Gentschev, I., G. Dietrich, S. Spreng, A. Kolb-Maurer, J. Daniels, J. Hess, S. H. Kaufmann, and W. Goebel. 2000. Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes. J. Biotechnol. 83:19-26.
16. Gomez-Duarte, O. G., B. Lucas, Z. X. Yan, K. Panthel, R. Haas, and T. F. Meyer. 1998. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 16:460-471.
17. Haddad, D., S. Liljeqvist, S. Kumar, M. Hansson, S. Stahl, H. Perlmann, P. Perlmann, and K. Berzins. 1995. Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity. FEMS Immunol. Med. Microbiol. 12:175-186.
18. Hayes, L. J., J. W. Conlan, J. S. Everson, M. E. Ward, and I. N. Clarke. 1991. Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain of Salmonella typhimurium; their application as potential immunogens. J. Gen. Microbiol. 137:1557-1564.
19. Henderson, I. R., and J. P. Nataro. 2001. Virulence functions of autotransporter proteins. Infect. Immun. 69:1231-1243.
20. Hess, J., I. Gentschev, D. Miko, M. Welzel, C. Ladel, W. Goebel, and S. H. Kaufmann. 1996. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93:1458-1463.
21. Hohmann, E. L., C. A. Oletta, W. P. Loomis, and S. I. Miller. 1995. Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity. Proc. Natl. Acad. Sci. USA 92:2904-2908.
22. Hoiseth, S. K., and B. A. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
23. Hussell, T., P. G. Isaacson, J. E. Crabtree, and J. Spencer. 1993. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571-574.
24. Janssen, R., and J. Tommassen. 1994. PhoE protein as a carrier for foreign epitopes. Int. Rev. Immunol. 11:113-121.
25. Jose, J., F. Jahnig, and T. F. Meyer. 1995. Common structural features of IgA1 protease-like outer membrane protein autotransporters. Mol. Microbiol. 18:378-380.
26. Jose, J., J. Kramer, T. Klauser, J. Pohlner, and T. F. Meyer. 1996. Absence of periplasmic DsbA oxidoreductase facilitates export of cysteine-containing passenger proteins to the Escherichia coli cell surface via the IgA beta autotransporter pathway. Gene 178:107-110.
27. Kjaergaard, K., H. Hasman, M. A. Schembri, and P. Klemm. 2002. Antigen 43-mediated autotransporter display, a versatile bacterial cell surface presentation system. J. Bacteriol. 184:4197-4204.
28. Klauser, T., J. Pohlner, and T. F. Meyer. 1990. Extracellular transport of cholera toxin B subunit using Neisseria IgA protease beta-domain: conformation-dependent outer membrane translocation. EMBO J. 9:1991-1999.
29. Konieczny, M. P., M. Suhr, A. Noll, I. B. Autenrieth, and M. A. Schmidt. 2000. Cell surface presentation of recombinant (poly-) peptides including functional T-cell epitopes by the AIDA autotransporter system. FEMS Immunol. Med. Microbiol. 27:321-332.
30. Kramer, U., K. Rizos, H. Apfel, I. B. Autenrieth, and C. T. Lattemann. 2003. Autodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains. Infect. Immun. 71:1944-1952.
31. Lattemann, C. T., J. Maurer, E. Gerland, and T. F. Meyer. 2000. Autodisplay: functional display of active beta-lactamase on the surface of Escherichia coli by the AIDA-I autotransporter. J. Bacteriol. 182:3726-3733.
32. Leclerc, C., A. Charbit, A. Molla, and M. Hofnung. 1989. Antibody response to a foreign epitope expressed at the surface of recombinant bacteria: importance of the route of immunization. Vaccine 7:242-248.
33. Lee, J. S., K. S. Shin, J. G. Pan, and C. J. Kim. 2000. Surface-displayed viral antigens on Salmonella carrier vaccine. Nat. Biotechnol. 18:645-648.
34. Londono-Arcila, P., D. Freeman, H. Kleanthous, A. M. O'Dowd, S. Lewis, A. K. Turner, E. L. Rees, T. J. Tibbitts, J. Greenwood, T. P. Monath, and M. J. Darsley. 2002. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect. Immun. 70:5096-5106.
35. + T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling. Infect. Immun. 69:1714-1721.
36. Maurer, J., J. Jose, and T. F. Meyer. 1997. Autodisplay: one-component system for efficient surface display and release of soluble recombinant proteins from Escherichia coli. J. Bacteriol. 179:794-804.
37. Maurer, J., J. Jose, and T. F. Meyer. 1999. Characterization of the essential transport function of the AIDA-I autotransporter and evidence supporting structural predictions. J. Bacteriol. 181:7014-7020.
38. Michetti, P., I. Corthesy-Theulaz, C. Davin, R. Haas, A. C. Vaney, M. Heitz, J. Bille, J. P. Kraehenbuhl, E. Saraga, and A. L. Blum. 1994. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 107:1002-1011.
39. + gene: application to cholera vaccine development. Gene 107:139-144.
40. Newton, S. M., C. O. Jacob, and B. A. Stocker. 1989. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244:70-72.
41. Parsonnet, J., S. Hansen, L. Rodriguez, A. B. Gelb, R. A. Warnke, E. Jellum, N. Orentreich, J. H. Vogelman, and G. D. Friedman. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330:1267-1271.
42. Ruiz-Perez, F., R. Leon-Kempis, A. Santiago-Machuca, G. Ortega-Pierres, E. Barry, M. Levine, and C. Gonzalez-Bonilla. 2002. Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL. Infect. Immun. 70:3611-3620.
43. Russmann, H., E. I. Igwe, J. Sauer, W. D. Hardt, A. Bubert, and G. Geginat. 2001. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J. Immunol. 167:357-365.
44. Russmann, H., H. Shams, F. Poblete, Y. Fu, J. E. Galan, and R. O. Donis. 1998. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281:565-568.
45. Shimada, K., Y. Ohnishi, S. Horinouchi, and T. Beppu. 1994. Extracellular transport of pseudoazurin of Alcaligenes faecalis in Escherichia coli using the COOH-terminal domain of Serratia marcescens serine protease. J. Biochem. (Tokyo) 116:327-334.
46. Spreng, S., G. Dietrich, W. Goebel, and I. Gentschev. 2003. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing protective listerial epitopes within a surface-exposed loop of the TolC-protein. Vaccine 21:746-752.
47. Tommassen, J., M. Agterberg, R. Janssen, and G. Spierings. 1993. Use of the enterobacterial outer membrane protein PhoE in the development of new vaccines and DNA probes. Zentralbl. Bakteriol. 278:396-406.
48. Wotherspoon, A. C., C. Doglioni, T. C. Diss, L. Pan, A. Moschini, M. de Boni, and P. G. Isaacson. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577.